Abstract

We develop novel biophotonic imaging for early-cancer detection, a grand challenge in cancer research, using nonionizing electromagnetic and ultrasonic waves. Unlike ionizing x-ray radiation, nonionizing electromagnetic waves such as optical waves are safe for biomedical applications and reveal new contrast mechanisms and functional information. For example, our spectroscopic oblique-incidence reflectometry can detect skin cancers based on functional hemoglobin parameters and cell nuclear size with 95% accuracy. Unfortunately, electromagnetic waves in the nonionizing spectral region do not penetrate biological tissue in straight paths as do x-rays. Consequently, high-resolution tomography based on nonionizing electromagnetic waves alone, as demonstrated by our Mueller optical coherence tomography, is limited to superficial tissue imaging. Ultrasonic imaging, on the contrary, furnishes good imaging resolution but has poor contrast in early-stage tumors and has strong speckle artifacts as well. We developed ultrasound-mediated imaging modalities by combining electromagnetic and ultrasonic waves synergistically. The hybrid modalities yield speckle-free electromagnetic-contrast at ultrasonic resolution in relatively large biological tissue. In ultrasound-modulated (acousto)-optical tomography, a focused ultrasonic wave encodes diffuse laser light in scattering biological tissue. In photo-acoustic (thermo-acoustic) tomography, a low-energy laser (RF) pulse induces ultrasonic waves in biological tissue due to thermoelastic expansion.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call